From: Healthcare utilization and costs for patients initiating Dabigatran or Warfarin

Outcome | Dabigatran | Warfarin |
P value^{b}
| |
---|---|---|---|---|

Total Cost, mean (95% CI) | ||||

Unadjusted GLM Mean | $2362 ($2213, $2521) | $2204 ($2065, $2352) | 0.1398 | |

Adjusted GLM Mean^{d}
| $2381 ($2106, $2700) | $2183 ($1929, $2481) | 0.0967 | |

Total Pharmacy Cost, mean (95% CI) | ||||

Unadjusted GLM Mean | $509 ($488, $531) | $251 ($240, $262) | <.0001 | |

Adjusted GLM Mean^{d}
| $510 ($470, $555) | $250 ($230, $273) | <.0001 | |

Total Medical Cost, mean (95% CI) | ||||

Unadjusted GLM Mean | $1903 ($1757, $2060) | $1973 ($1823, $2135) | 0.5276 | |

Adjusted GLM Mean^{d}
| $1912 ($1646, $2231) | $1956 ($1683, $2286) | 0.5500 | |

Hospital-related All-Cause Medical Cost, mean (95% CI) | ||||

Unadjusted GLM Mean | $1534 ($1283, $1833) | $1596 ($1338, $1903) | 0.7552 | |

Adjusted GLM Mean^{d}
| $1094 ($821, $1480) | $1137 ($851, $1539) | 0.6607 | |

ER related All-Cause Medical Cost, mean (95% CI) | ||||

Unadjusted GLM Mean | $73 ($65, $83) | $82 ($73, $92) | 0.2036 | |

Adjusted GLM Mean^{d}
| $72 ($58, $91) | $83 ($66, $104) | 0.0967 | |

Physician office visits related All-Cause Medical Cost, mean (95% CI) | ||||

Unadjusted GLM Mean | $285 ($269, $303) | $287 ($270, $305) | 0.8929 | |

Adjusted GLM Mean^{d}
| $282 ($252, $317) | $289 ($258, $326) | 0.3792 | |

Outpatient visits related All-Cause Medical Cost, mean (95% CI) | ||||

Unadjusted GLM Mean | $399 ($361, $441) | $360 ($325, $398) | 0.1554 | |

Adjusted GLM Mean^{d}
| $396 ($327, $482) | $362 ($300, $445) | 0.3120 |